Imaging Features of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Multicenter Study

por Wu, Jun-Yi, Huang, Li-Ming, Bai, Yan-Nan, Wu, Jia-Yi, Wei, Yong-Gang, Zhang, Zhi-Bo, Yan, Mao-Lin
Publicado 2021

Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Tran...

por Luo, Meng-Chao, Wu, Jia-Yi, Wu, Jun-Yi, Lin, Zhong-Tai, Li, Yi-Nan, Zeng, Zhen-Xin, Wei, Shao-Ming, Yan, Mao-Lin
Publicado 2023

Mutational Analysis of a Familial Adenomatous Polyposis Pedigree with Bile Duct Polyp Phenotype

por Xie, Li-jun, Ruan, Dan-dan, Zhang, Jian-hui, Li, Yi, Chen, Li, Yan, Mao-lin, Yu, Ming-dian, Luo, Jie-wei, Zhang, Hui-zhen
Publicado 2021

Outcomes of laparoscopic bile duct exploration for choledocholithiasis with small common bile duct

por Huang, Xiao-Xiao, Wu, Jia-Yi, Bai, Yan-Nan, Wu, Jun-Yi, Lv, Jia-Hui, Chen, Wei-Zhao, Huang, Li-Ming, Huang, Rong-Fa, Yan, Mao-Lin
Publicado 2021

A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma

por Wu, Jun-Yi, Sun, Ju-Xian, Wu, Jia-Yi, Huang, Xiao-Xiao, Bai, Yan-Nan, Zeng, Yong-Yi, Zhang, Zhi-Bo, Cheng, Shu-Qun, Yan, Mao-Lin
Publicado 2021

Lenvatinib combined with anti-PD-1 antibodies plus transcatheter arterial chemoembolization for neoadjuvant treatment of resectable hepatocellular carcinoma with high risk of recur...

por Wu, Jun-Yi, Wu, Jia-Yi, Li, Yi-Nan, Qiu, Fu-Nan, Zhou, Song-Qiang, Yin, Zhen-Yu, Chen, Yu-Feng, Li, Bin, Zhou, Jian-Yin, Yan, Mao-Lin
Publicado 2022

Concurrent bile duct resection versus concomitant thrombectomy for hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis

por Feng, Jin-Kai, Chen, Zhen-Hua, Sun, Ju-Xian, Wu, Jia-Yi, Guo, Wei-Xing, Shi, Jie, Wei, Yong-Gang, Zhou, Jian-Yin, Zhang, Zhi-Bo, Yan, Mao-Lin, Cheng, Shu-Qun
Publicado 2021

Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

por Wu, Jia-Yi, Yin, Zhen-Yu, Bai, Yan-Nan, Chen, Yu-Feng, Zhou, Song-Qiang, Wang, Shuang-Jia, Zhou, Jian-Yin, Li, Yi-Nan, Qiu, Fu-Nan, Li, Bin, Yan, Mao-Lin
Publicado 2021

Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective study

por Yang, Shi-Ye, Yan, Mao-Lin, Feng, Jin-Kai, Duan, Yun-Fei, Ye, Jia-Zhou, Liu, Zong-Han, Guo, Lei, Xue, Jie, Shi, Jie, Lau, Wan Yee, Cheng, Shu-Qun, Guo, Wei-Xing
Publicado 2022

Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

por Li, Shu-Qun, Wu, Jun-Yi, Wu, Jia-Yi, Xie, Huang, Li, Jin-Hai, Zeng, Zhen-Xin, Fu, Yang-Kai, Liu, De-Yi, Li, Han, Chen, Wei-Zhao, Huang, Jing-Yao, Yan, Mao-Lin
Publicado 2023

Significance of anatomical resection and resection margin status in patients with HBV-related hepatocellular carcinoma and microvascular invasion: a multicenter propensity score-ma...

por Zhang, Xiu-Ping, Xu, Shuai, Lin, Zhao-Yi, Gao, Qing-Lun, Wang, Kang, Chen, Zi-Li, Yan, Mao-Lin, Zhang, Fan, Tang, Yu-Fu, Zhao, Zhi-Ming, Li, Cheng-Gang, Lau, Wan Yee, Cheng, Shu-Qun, Hu, Ming-Gen, Liu, Rong
Publicado 2023

Outcomes of Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma Converted by Transcatheter Arterial Chemoembolization Combined with Lenvatinib plus Anti-PD-1 Antibo...

por Wu, Jia-Yi, Zhang, Zhi-Bo, Zhou, Jian-Yin, Ke, Jing-Peng, Bai, Yan-Nan, Chen, Yu-Feng, Wu, Jun-Yi, Zhou, Song-Qiang, Wang, Shuang-Jia, Zeng, Zhen-Xin, Li, Yi-Nan, Qiu, Fu-Nan, Li, Bin, Yan, Mao-Lin
Publicado 2022